Pennington, NJ, United States of America

Tram N Huynh

This inventor holds 16 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tram N Huynh. Retrieved from https://idiyas.com/inventor/tram-n-huynh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 7.8

ph-index = 5

Forward Citations = 129(Granted Patents)

Company Filing History:

16 out of 3,737

Bristol-Myers Squibb Compnay

patents

Years Active: 2006-2026

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12673954 - Benzofuran compounds as sting agonists (2026-07-07),

2. 10450318 - CXCR4 receptor antagonists (2019-10-22),

3. 10196387 - Carbazole compounds useful as bromodomain inhibitors (2019-02-05),

4. 10112975 - Benzodiazepine dimers, conjugates thereof, and methods of making and using (2018-10-30),

5. 10053454 - Carbazole compounds useful as bromodomain inhibitors (2018-08-21),

6. 9822144 - Benzodiazepine dimers, conjugates thereof, and methods of making and using (2017-11-21),

7. 9676794 - Benzodiazepine dimers, conjugates thereof, and methods of making and using (2017-06-13),

8. 9556178 - Imidazotriazinecarbonitriles useful as kinase inhibitors (2017-01-31),

9. 9527871 - Benzodiazepine dimers, conjugates thereof, and methods of making and using (2016-12-27),

10. 9273057 - Imidazotriazinecarbonitriles useful as kinase inhibitors (2016-03-01),

11. 8940736 - Imidazotriazinecarbonitriles useful as kinase inhibitors (2015-01-27),

12. 7968577 - Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof (2011-06-28),

13. 7723336 - Fused heterocyclic compounds useful as kinase modulators (2010-05-25),

14. 7439246 - Fused heterocyclic kinase inhibitors (2008-10-21),

15. 7173031 - Pyrrolotriazine kinase inhibitors (2007-02-06),

Title: Tram N Huynh: Innovator in Pharmaceutical Compounds

Introduction

Tram N Huynh is a prominent inventor based in Pennington, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors and disorders. With a total of 16 patents to her name, her work has the potential to impact therapeutic practices significantly.

Latest Patents

Among her latest inventions are the CXCR4 receptor antagonists. This invention relates to compounds of formula I, which serve as antagonists of CXCR4. The invention encompasses pharmaceutically acceptable salts, compositions, methods of making the compounds, and methods of using them for therapeutic indications. Another notable patent is for carbazole compounds useful as bromodomain inhibitors. This invention focuses on carbazole compounds, along with pharmaceutically acceptable compositions that include these compounds, and methods for using these compositions in treating various disorders.

Career Highlights

Tram N Huynh is currently associated with Bristol-Myers Squibb Company, where she continues to innovate and contribute to the pharmaceutical industry. Her work is characterized by a commitment to developing effective therapeutic solutions.

Collaborations

She has collaborated with notable colleagues, including Wayne D Vaccaro and Robert Michael Borzilleri, enhancing the scope and impact of her research.

Conclusion

Tram N Huynh's contributions to pharmaceutical innovations demonstrate her expertise and dedication to improving health outcomes through her inventions. Her work continues to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.